Health Disparities in Endocrine Disorders: Biological, Clinical, and Nonclinical Factors—An Endocrine Society Scientific Statement

Sherita Hill Golden; Arleen Brown; Jane A. Cauley; Marshall H. Chin; Tiffany L. Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E. Sumner; Blair Anton

首页> 外文期刊>The journal of clinical endocrinology and metabolism >Health Disparities in Endocrine Disorders: Biological, Clinical, and Nonclinical Factors—An Endocrine Society Scientific Statement

【24h】

Health Disparities in Endocrine Disorders: Biological, Clinical, and Nonclinical Factors—An Endocrine Society Scientific Statement

机译：内分泌失调的健康差异：生物学，临床和非临界因素 - 内分泌社会科学陈述

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective:The aim was to provide a scholarly review of the published literature on biological, clinical, and nonclinical contributors to race/ethnic and sex disparities in endocrine disorders and to identify current gaps in knowledge as a focus for future research needs.

机译：目的：目的是提供对生物，临床和非临床贡献者对内分泌疾病的种族/族裔和性差异的出版文献的学术审查，并确定当前知识的差距作为未来的研究需求的重点。

著录项

来源
《The journal of clinical endocrinology and metabolism》 |2012年第9期|共61页
作者
Sherita Hill Golden; Arleen Brown; Jane A. Cauley; Marshall H. Chin; Tiffany L. Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E. Sumner; Blair Anton;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Assessment and management of bone health in women with oestrogen receptor‐positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia [J] . Grossmann Mathis, Ramchand Sabashini K., Milat Frances, Clinical Endocrinology . 2018,第3期

机译：雌激素受体阳性乳腺癌患者骨骼健康的评估和管理接受内分泌治疗：澳大利亚内分泌会的立场声明，澳大利亚和新西兰骨骼社会，澳大利亚绝经和澳大利亚临床肿瘤学会
2. Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement [J] . William F. Young Jr., David A. Calhoun, Jacques W.M. Lenders, Endocrine Reviews . 2017,第2期

机译：内分泌高血压筛查：内分泌学会科学声明
3. Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals [J] . A. C. Gore, V. A. Chappell, S. E. Fenton, Endocrine Reviews . 2015,第6期

机译：EDC-2的执行摘要：内分泌学会关于破坏内分泌化学物质的第二份科学声明
4. High Speed TOF-MS for GC and GCxGC Endocrine Disrupting Compounds Characterization in Biological Samples for Environmental Risk Factors Assessment [C] . Daniela Cavagnino, Antonella Siviero, Alessandra Mantegazza, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：高速TOF-MS用于GC和GCXGC内分泌破坏生物样本中的化合物表征，用于环境风险因素评估
5. The Life History Significance of Human Breast Milk: Immune and endocrine factors as indicators of maternal condition and predictors of infant health and growth. [D] . Breakey, Alicia Ann. 2015

机译：母乳的生命史意义：免疫和内分泌因素可作为孕产妇状况的指标以及婴儿健康和成长的指标。
6. Health Disparities in Endocrine Disorders: Biological Clinical and Nonclinical Factors—An Endocrine Society Scientific Statement [O] . Sherita Hill Golden, Arleen Brown, Jane A. Cauley, -1

机译：内分泌疾病的健康差异：生物学临床和非临床因素—内分泌学会的科学声明
7. Health disparities in endocrine disorders: Biological, clinical, and nonclinical factors - An endocrine society scientific statement [O] . Golden, SH, Brown, A, Cauley, JA, 2012

机译：内分泌疾病的健康差异：生物学，临床和非临床因素-内分泌学会的科学陈述

Health Disparities in Endocrine Disorders: Biological, Clinical, and Nonclinical Factors—An Endocrine Society Scientific Statement

摘要

著录项

相似文献

相关主题

期刊订阅